You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Other Lab Tests Articles
Popular Other Lab Tests Articles
Highly Recommended Other Lab Tests Articles
Send a link to this page to your friends and colleagues.
A joint study by the University of Minnesota and the University of California San Francisco, with one islet cell infusion from a single donor pancreas, has achieved insulin independence in four of six people with longterm type 1 diabetes.
Four recipients have been insulin independent for more than one year; three for over two years, and two for more than three years.
A new type of anti-rejection treatment was developed and administered in the trial. A new generation of anti-CD3 monoclonal antibody was administered in this study during the first two weeks after transplant. This antibody targets the type of white blood cells that cause type 1 diabetes and mediate rejection of transplants.
Study participants received two other immune-suppression drugs. Current studies are testing whether the longterm maintenance immune-suppression medication can be minimized or even discontinued in islet cell recipients given the anti-CD3 antibody.
The study’s success can be attributed to better islet cell preparation and optimized anti-rejection drugs, according to the researchers.
-Diabetes Care, March 2004
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.